推荐产品
化驗
99% (LPS; may contain up to 15% of the 2-LPS isomer, TLC)
形狀
liquid
包裝
pkg of 1 × 1 mL (858141C-5mg)
pkg of 1 × 4 mL (858141C-100mg)
製造商/商標名
Avanti Research™ - A Croda Brand 858141C
濃度
25 mg/mL (858141C-100mg)
5 mg/mL (858141C-5mg)
脂質類型
phospholipids
cardiolipins
運輸包裝
dry ice
儲存溫度
−20°C
SMILES 字串
O[C@](COP([O-])(OC[C@](C([O-])=O)([H])[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[Na+]
應用
17:1 Lyso PS may be used as a standard in graphitized carbon black-solid phase extraction (GCB-SPE) method for lipid extraction. It may also be used as an internal standard in the metabolomic analysis of cell and brain samples.
生化/生理作用
17:1 Lyso PS may serve as an odd-chained LIPIDOMIX™quantitative mass spectrometry internal standard.
包裝
5 mL Clear Glass Sealed Ampule (858141C-100mg)
5 mL Clear Glass Sealed Ampule (858141C-5mg)
法律資訊
Avanti Research is a trademark of Avanti Polar Lipids, LLC
LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC
訊號詞
Danger
危險分類
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
標靶器官
Liver,Kidney, Respiratory system
儲存類別代碼
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
水污染物質分類(WGK)
WGK 3
閃點(°F)
does not flash
閃點(°C)
does not flash
Nature chemical biology, 14(12), 1099-1108 (2018-11-14)
ABHD12 metabolizes bioactive lysophospholipids, including lysophosphatidylserine (lyso-PS). Deleterious mutations in human ABHD12 cause the neurological disease PHARC, and ABHD12-/- mice display PHARC-like phenotypes, including hearing loss, along with elevated brain lyso-PS and features of stimulated innate immune cell function. Here
Life sciences, 245, 117352-117352 (2020-02-02)
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipose tissue (WAT), which plays a central role in its distinct response to outside stimuli. However, the detailed lipidome of depot-specific
Biochemistry, 57(39), 5759-5767 (2018-09-18)
Deleterious mutations in the serine hydrolase DDHD domain containing 1 (DDHD1) cause the SPG28 subtype of the neurological disease hereditary spastic paraplegia (HSP), which is characterized by axonal neuropathy and gait impairments. DDHD1 has been shown to display PLA1-type phospholipase
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门